The reaction of NQO1 with β-lapachone exerts beneficial effects on symptoms of aging, obesity, hypertension, arterial restenosis, acute pancreatitis, cisplatin-mediated acute kidney injury, and hearing impairment (32–34). This evidence concerns the gene NQO1 and obesity due to melanocortin 4 receptor deficiency.